Coxsackievirus A16-like particles elicit neutralizing antibody responses in mice
2011

Coxsackievirus A16 Vaccine Candidate Shows Promise in Mice

publication Evidence: moderate

Author Information

Author(s): Liu Qingwei, Yan Kexia, Feng Yanfang, Cai Yicun, Huang Zhong

Primary Institution: Key laboratory of Molecular Virology & Immunology, Institute Pasteur of Shanghai, Chinese Academy of Sciences

Hypothesis

Can Coxsackievirus A16 virus-like particles elicit neutralizing antibody responses in mice?

Conclusion

Coxsackievirus A16 virus-like particles can generate strong neutralizing antibody responses in mice, indicating potential as a vaccine candidate.

Supporting Evidence

  • Coxsackievirus A16 is a major cause of hand, foot, and mouth disease.
  • No vaccine for hand, foot, and mouth disease is currently available.
  • Virus-like particles were produced by co-expressing specific viral proteins.
  • Mice immunized with the virus-like particles produced high levels of specific antibodies.
  • The antibodies generated were effective at neutralizing live Coxsackievirus A16.

Takeaway

Scientists made a new type of vaccine from a virus that causes a sickness called hand, foot, and mouth disease, and it worked well in mice.

Methodology

The study involved producing virus-like particles from Coxsackievirus A16 and testing their immunogenicity in mice.

Participant Demographics

Mice were used in the study.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication